These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

911 related articles for article (PubMed ID: 15932439)

  • 21. [Axillary recurrences after sentinel lymph node biopsy in initial breast cancer].
    Sampol C; Giménez M; Torrecabota J; Serra C; Canet R; Daumal J; Peña C; Gonzalez L; Hernandez E; Graner A; Pozo A; Vega F
    Rev Esp Med Nucl; 2010; 29(5):241-5. PubMed ID: 20466461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paradigm shift in axilla surgery for breast cancer patients treated with sentinel node biopsy.
    Imoto S; Isaka H; Sakemura N; Ito H; Imi K; Miyamoto K
    Breast Cancer; 2012 Apr; 19(2):104-9. PubMed ID: 22038672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
    Fujii T; Yajima R; Tatsuki H; Kuwano H
    Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medium-term follow-up data after sentinel node biopsy alone for breast cancer.
    Haid A; Knauer M; Köberle-Wührer R; Ammann K; Koller L; Eiter H; Lang A; Wenzl E
    Eur J Surg Oncol; 2006 Dec; 32(10):1180-5. PubMed ID: 16750344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial.
    Gill G;
    Ann Surg Oncol; 2009 Feb; 16(2):266-75. PubMed ID: 19050973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast lymphoscintigraphy for sentinel node identification in breast cancers with clinically-negative axillary nodes.
    Namwongprom S; Boonyaprapa S; Ekmahachai M; Vilasdechanon N; Somwangprasert A; Sumitsawan S; Taya P
    Singapore Med J; 2005 Dec; 46(12):688-92. PubMed ID: 16308641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure.
    Derkx F; Maaskant-Braat AJ; van der Sangen MJ; Nieuwenhuijzen GA; van de Poll-Franse LV; Roumen RM; Voogd AC
    Eur J Surg Oncol; 2010 Jul; 36(7):646-51. PubMed ID: 20537838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer.
    Konstantiniuk P; Schrenk P; Reitsamer R; Koeberle-Wuehrer R; Tausch C; Roka S; Riedl O; Poestlberger S; Hecke D; Janauer M; Haid A
    Breast; 2007 Oct; 16(5):520-6. PubMed ID: 17566737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node.
    de Widt-Levert L; Tjan-Heijnen V; Bult P; Ruers T; Wobbes T
    Eur J Surg Oncol; 2003 Apr; 29(3):216-20. PubMed ID: 12657229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognostic and curative value of sentinel node in breast cancer. A 377 patients experience].
    Iannace C; Di Libero L; Lepore M; De Stefano N; Buono M; Sciascia V; Manetta F; Giordano M; Scetta G; Varriale R; Esposito D; Tartaglia E; Ferbo U; Miletto P; Caracciolo F
    Ann Ital Chir; 2010; 81(2):103-11; discussion 112-3. PubMed ID: 20726388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
    Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
    Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study.
    Veronesi U; Viale G; Paganelli G; Zurrida S; Luini A; Galimberti V; Veronesi P; Intra M; Maisonneuve P; Zucca F; Gatti G; Mazzarol G; De Cicco C; Vezzoli D
    Ann Surg; 2010 Apr; 251(4):595-600. PubMed ID: 20195151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicentric breast cancer: a new indication for sentinel node biopsy--a multi-institutional validation study.
    Knauer M; Konstantiniuk P; Haid A; Wenzl E; Riegler-Keil M; Pöstlberger S; Reitsamer R; Schrenk P
    J Clin Oncol; 2006 Jul; 24(21):3374-80. PubMed ID: 16849751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
    Enokido K; Watanabe C; Nakamura S; Ogiya A; Osako T; Akiyama F; Yoshimura A; Iwata H; Ohno S; Kojima Y; Tsugawa K; Motomura K; Hayashi N; Yamauchi H; Sato N
    Clin Breast Cancer; 2016 Aug; 16(4):299-304. PubMed ID: 26993216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?
    Port ER; Patil S; Stempel M; Morrow M; Cody HS
    Cancer; 2010 Apr; 116(8):1987-91. PubMed ID: 20151427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: Long-term results of a retrospective study.
    Martelli G; Miceli R; Folli S; Guzzetti E; Chifu C; Maugeri I; Ferranti C; Bianchi G; Capri G; Carcangiu ML; Paolini B; Agresti R; Ferraris C; Piromalli D; Greco M
    Eur J Surg Oncol; 2017 Nov; 43(11):2012-2020. PubMed ID: 28912071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells.
    Pepels MJ; de Boer M; Bult P; van Dijck JA; van Deurzen CH; Menke-Pluymers MB; van Diest PJ; Borm GF; Tjan-Heijnen VC
    Ann Surg; 2012 Jan; 255(1):116-21. PubMed ID: 22183034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Incidence of axillary recurrence after a negative sentinel lymph node result in early stages of breast cancer: a 5-year follow-up].
    Ruano Pérez R; Ramos Boyero M; García-Talavera Fernández JR; Ramos Grande T; González-Orús JM; Gómez-Caminero López F; García Macias MC; Martín de Arriba A
    Rev Esp Med Nucl Imagen Mol; 2012; 31(4):173-7. PubMed ID: 23067685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.